About service
In the field of obstetrics and gynecology, two parallel trends are observed: on the one hand, menopause is occurring at a younger age, and on the other hand, the number of women giving birth for the first time after the age of 35 is increasing. The desired offspring may be hindered by premature ovarian insufficiency (POI). Below, we discuss the causes, prevention, and treatment.
Definition
Premature ovarian insufficiency (POI) is a condition in which a woman’s ovaries do not produce sufficient estrogen to maintain regular menstrual cycles and fertility. This syndrome is also known as premature menopause. Menopause is the last menstrual period in a woman’s life, which on average occurs at the age of 50. If it occurs earlier, physicians speak of early menopause, and if it occurs before the age of 40, the diagnosis of premature menopause may be established.
POI usually develops before the age of 40 in women who previously had no ovarian health problems. The causes may include genetic abnormalities, autoimmune diseases, chronic diseases, exposure to certain medications, or surgical interventions on the ovaries. Premature ovarian insufficiency is a serious condition that requires careful medical monitoring and treatment.
Symptoms
Early warning signs of premature ovarian insufficiency include:
hot flashes, excessive sweating (about 80% of women react to estrogen decline with thermoregulation disturbances),
discomfort during sexual intercourse,
vaginal dryness,
weight gain,
decreased libido,
significant shortening of the menstrual cycle,
scanty menstrual bleeding,
edema and chills before menstruation,
rapid development of osteoporosis,
sleep disturbances, memory and concentration problems,
emotional instability.
Causes
The exact causes of premature ovarian failure are not fully known. However, the following factors may contribute:
Genetic factors: insufficient follicle reserve established during intrauterine development; genetic disorders such as blepharophimosis or galactosemia.
Inflammatory processes: endometritis, colpitis, parametritis, salpingo-oophoritis, cervicitis.
Autoimmune processes: autoantibody production leading to follicular tissue replacement with fibrosis.
Stress: elevated cortisol and prolactin levels negatively affecting ovarian function, along with suppression of immune defenses.
Unbalanced nutrition: insufficient intake of protein, fat, and iron adversely affects follicular quality.
Endometriosis: the disease itself and its hormonal treatment reduce ovarian reserves.
Ovarian surgery: surgical procedures may cause pelvic adhesions and scarring.
In vitro fertilization (IVF): multiple attempts may deplete ovarian resources.
Ovarian tumors: neoplasms may damage healthy follicular tissue.
Chemotherapy/radiation therapy: effective against malignancies but harmful to the ovaries.
Diagnosis
Diagnosis begins with medical history and gynecological examination, followed by:
Laboratory tests: assessment of sex hormones (LH, FSH, estradiol, prolactin, 17-OH testosterone) between days 3–5 of the menstrual cycle, as well as iron, magnesium, and B vitamins.
Pelvic ultrasound: performed on days 7–8 of the cycle; if amenorrhea persists for 3 months, ultrasound can be done on any day to assess follicle count and endometrial thickness.
Family history assessment: genetic counseling may be recommended.
Ovarian biopsy: in selected cases when other diagnostic methods are inconclusive.
Additional tests: thyroid function, chest radiography, urine analysis, to rule out differential diagnoses.
Overall, diagnosis of POI is complex and requires a multidisciplinary approach.
Treatment
Management may include hormone replacement therapy (HRT), assisted reproductive technologies (ART), or other methods depending on the underlying cause. Medications stimulating ovarian function may be used to restore menstrual cycles and improve conception chances, though this is not effective in all cases.
⚠️ Self-prescribing hormonal therapy is dangerous and may lead to severe adverse effects, including oncological complications. Only medications and supplements prescribed by a physician should be taken.
Premature ovarian insufficiency (POI) is a condition in which a woman’s ovaries do not produce sufficient estrogen to maintain regular menstrual cycles and fertility. This syndrome is also known as premature menopause. Menopause is the last menstrual period in a woman’s life, which on average occurs at the age of 50. If it occurs earlier, physicians speak of early menopause, and if it occurs before the age of 40, the diagnosis of premature menopause may be established.
POI usually develops before the age of 40 in women who previously had no ovarian health problems. The causes may include genetic abnormalities, autoimmune diseases, chronic diseases, exposure to certain medications, or surgical interventions on the ovaries. Premature ovarian insufficiency is a serious condition that requires careful medical monitoring and treatment.
Symptoms
Early warning signs of premature ovarian insufficiency include:
hot flashes, excessive sweating (about 80% of women react to estrogen decline with thermoregulation disturbances),
discomfort during sexual intercourse,
vaginal dryness,
weight gain,
decreased libido,
significant shortening of the menstrual cycle,
scanty menstrual bleeding,
edema and chills before menstruation,
rapid development of osteoporosis,
sleep disturbances, memory and concentration problems,
emotional instability.
Causes
The exact causes of premature ovarian failure are not fully known. However, the following factors may contribute:
Genetic factors: insufficient follicle reserve established during intrauterine development; genetic disorders such as blepharophimosis or galactosemia.
Inflammatory processes: endometritis, colpitis, parametritis, salpingo-oophoritis, cervicitis.
Autoimmune processes: autoantibody production leading to follicular tissue replacement with fibrosis.
Stress: elevated cortisol and prolactin levels negatively affecting ovarian function, along with suppression of immune defenses.
Unbalanced nutrition: insufficient intake of protein, fat, and iron adversely affects follicular quality.
Endometriosis: the disease itself and its hormonal treatment reduce ovarian reserves.
Ovarian surgery: surgical procedures may cause pelvic adhesions and scarring.
In vitro fertilization (IVF): multiple attempts may deplete ovarian resources.
Ovarian tumors: neoplasms may damage healthy follicular tissue.
Chemotherapy/radiation therapy: effective against malignancies but harmful to the ovaries.
Diagnosis
Diagnosis begins with medical history and gynecological examination, followed by:
Laboratory tests: assessment of sex hormones (LH, FSH, estradiol, prolactin, 17-OH testosterone) between days 3–5 of the menstrual cycle, as well as iron, magnesium, and B vitamins.
Pelvic ultrasound: performed on days 7–8 of the cycle; if amenorrhea persists for 3 months, ultrasound can be done on any day to assess follicle count and endometrial thickness.
Family history assessment: genetic counseling may be recommended.
Ovarian biopsy: in selected cases when other diagnostic methods are inconclusive.
Additional tests: thyroid function, chest radiography, urine analysis, to rule out differential diagnoses.
Overall, diagnosis of POI is complex and requires a multidisciplinary approach.
Treatment
Management may include hormone replacement therapy (HRT), assisted reproductive technologies (ART), or other methods depending on the underlying cause. Medications stimulating ovarian function may be used to restore menstrual cycles and improve conception chances, though this is not effective in all cases.
⚠️ Self-prescribing hormonal therapy is dangerous and may lead to severe adverse effects, including oncological complications. Only medications and supplements prescribed by a physician should be taken.
+7 (495) 154-21-44 
admin@expertclinics.ru 
Moscow, Starovolynskaya st., 12 bld. 1